Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Greenleaf Peter 0000899243-18-013845.pdf 0000899243-18-013845.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Davis Todd C 0000899243-18-013847.pdf 0000899243-18-013847.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Broadfin Capita 0000899243-18-013846.pdf 0000899243-18-013846.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-170236.pdf 0001193125-18-170236.rtf 0001193125-18-170236.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-168702.pdf 0001193125-18-168702.rtf 0001193125-18-168702.xls View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
0000921895-18-001770.pdf 0000921895-18-001770.rtf 0000921895-18-001770.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-166035.pdf 0001193125-18-166035.rtf 0001193125-18-166035.xls View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3
Registration Statements
0001193125-18-166065.pdf 0001193125-18-166065.rtf 0001193125-18-166065.xls View HTML

FWP

FWP
Other
0001193125-18-166075.pdf 0001193125-18-166075.rtf 0001193125-18-166075.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-161002.pdf 0001193125-18-161002.rtf 0001193125-18-161002.xls View HTML

Copyright Morningstar